Maxime Bouvier
Fribourg, FR, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Rapid ESBL-Carba Combo PN test for simultaneous detection of ESBL and carbapenemase activity in Enterobacterales.
Journal: Microbiology spectrum
Published: September 02, 2026
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolates.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: March 19, 2026
Inhibitory activity of meso-dimercaptosuccinic acid against IMP metallo-β-lactamase variants in Pseudomonas aeruginosa.
Journal: FEMS microbiology letters
Published: February 24, 2025
Rapid detection of cefepime-taniborbactam susceptibility/resistance in Enterobacterales.
Journal: International journal of antimicrobial agents
Published: February 10, 2025
The NitroSpeed Taniborbactam NP test as a rapid test for detection of β-lactamase-mediated susceptibility to taniborbactam.
Journal: FEMS microbiology letters
Published: December 12, 2024
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa.
Journal: The Journal of antimicrobial chemotherapy
Published: December 10, 2024
In-Vitro Activity of Dimercaptosuccinic Acid in Combination with Carbapenems Against Carbapenem-Resistant Pseudomonas aeruginosa.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: November 25, 2024
A Selective Culture Medium for Screening Aztreonam-Avibactam Resistance in Enterobacterales and Pseudomonas aeruginosa.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: November 22, 2024
Exogenous hydrogen sulphide sensitizes carbapenemase-producing Acinetobacter baumannii to gentamicin.
Journal: Journal of global antimicrobial resistance
Published: September 24, 2024
Rapid detection of imipenem/relebactam susceptibility/resistance in Pseudomonas aeruginosa.
Journal: Diagnostic microbiology and infectious disease
Published: May 28, 2024
In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: April 09, 2024
Last Updated: 09/26/2026